NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,092,422 | -27.4% | 525,100 | -4.0% | 0.03% | -25.7% |
Q2 2023 | $13,904,740 | -28.2% | 547,000 | +2.1% | 0.04% | -30.0% |
Q1 2023 | $19,361,940 | +34.6% | 535,600 | +47.5% | 0.05% | +25.0% |
Q4 2022 | $14,382,720 | -16.5% | 363,200 | -1.8% | 0.04% | -20.0% |
Q3 2022 | $17,233,000 | +23.3% | 369,800 | +16.0% | 0.05% | +25.0% |
Q2 2022 | $13,973,000 | -19.5% | 318,800 | +32.9% | 0.04% | -13.0% |
Q1 2022 | $17,352,000 | +57.6% | 239,900 | +76.7% | 0.05% | +64.3% |
Q4 2021 | $11,009,000 | -19.2% | 135,800 | +39.0% | 0.03% | -24.3% |
Q1 2021 | $13,629,000 | -42.1% | 97,700 | -28.1% | 0.04% | -41.3% |
Q4 2020 | $23,524,000 | -1.1% | 135,900 | -20.4% | 0.06% | -7.4% |
Q3 2020 | $23,779,000 | -14.2% | 170,700 | -26.5% | 0.07% | -16.0% |
Q2 2020 | $27,729,000 | +8.5% | 232,100 | -9.2% | 0.08% | -17.3% |
Q1 2020 | $25,545,000 | +42.1% | 255,500 | +67.1% | 0.10% | +133.3% |
Q4 2019 | $17,972,000 | +2471.1% | 152,900 | +2182.1% | 0.04% | +1300.0% |
Q3 2016 | $699,000 | +31.4% | 6,700 | -32.3% | 0.00% | -25.0% |
Q2 2015 | $532,000 | – | 9,901 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
Venator Management LLC | 25,000 | $480,500 | 0.18% |
DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |